{"count": 16, "results": [{"_id": "37945977", "pmid": 37945977, "pmcid": "PMC10805839", "title": "A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension", "journal": "Am J Cardiovasc Drugs", "authors": ["Nabeh OA", "Saud AI", "Amin B", "Khedr AS", "Amr A", "Faoosa AM", "Esmat E", "Mahmoud YM", "Hatem A", "Mohamed M", "Osama A", "Soliman YMA", "Elkorashy RI", "Elmorsy SA"], "date": "2023-11-09T00:00:00Z", "doi": "10.1007/s40256-023-00613-5", "meta_date_publication": "2023 Nov 9", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50278.82, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and sotatercept appear as promising therapeutic drugs for @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@PAH@@@.", "citations": {"NLM": "Nabeh OA, Saud AI, Amin B, Khedr AS, Amr A, Faoosa AM, Esmat E, Mahmoud YM, Hatem A, Mohamed M, Osama A, Soliman YMA, Elkorashy RI, Elmorsy SA. A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension Am J Cardiovasc Drugs. 2023 Nov 9;():. PMID: 37945977", "BibTeX": "@article{37945977, title={A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension}, author={Nabeh OA and Saud AI and Amin B and Khedr AS and Amr A and Faoosa AM and Esmat E and Mahmoud YM and Hatem A and Mohamed M and Osama A and Soliman YMA and Elkorashy RI and Elmorsy SA}, journal={Am J Cardiovasc Drugs}}"}}, {"_id": "33167773", "pmid": 33167773, "pmcid": "PMC7763730", "title": "Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension", "journal": "J Am Heart Assoc", "authors": ["Brittain EL", "Niswender K", "Agrawal V", "Chen X", "Fan R", "Pugh ME", "Rice TW", "Robbins IM", "Song H", "Thompson C", "Ye F", "Yu C", "Zhu H", "West J", "Newman JH", "Hemnes AR"], "date": "2020-11-17T00:00:00Z", "doi": "10.1161/JAHA.120.018349", "meta_date_publication": "2020 Nov 17", "meta_volume": "9", "meta_issue": "22", "meta_pages": "e018349", "score": 50269.22, "text_hl": "Mechanistic Phase II Clinical Trial of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@Pulmonary Arterial Hypertension@@@", "citations": {"NLM": "Brittain EL, Niswender K, Agrawal V, Chen X, Fan R, Pugh ME, Rice TW, Robbins IM, Song H, Thompson C, Ye F, Yu C, Zhu H, West J, Newman JH, Hemnes AR. Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension J Am Heart Assoc. 2020 Nov 17;9(22):e018349. PMID: 33167773", "BibTeX": "@article{33167773, title={Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension}, author={Brittain EL and Niswender K and Agrawal V and Chen X and Fan R and Pugh ME and Rice TW and Robbins IM and Song H and Thompson C and Ye F and Yu C and Zhu H and West J and Newman JH and Hemnes AR}, journal={J Am Heart Assoc}, volume={9}, number={22}, pages={e018349}}"}}, {"_id": "40371328", "pmid": 40371328, "title": "Pulmonary artery-targeted low-dose metformin-loaded nanocapsules safely improve pulmonary arterial hypertension in rats.", "journal": "Front Pharmacol", "authors": ["Chida-Nagai A", "Masaki N", "Sato H", "Kato T", "Takakuwa E", "Matsuno Y", "Manabe A", "Takeda A"], "date": "2025-04-30T00:00:00Z", "doi": "10.3389/fphar.2025.1577570", "meta_date_publication": "2025", "meta_volume": "16", "meta_issue": "", "meta_pages": "1577570", "score": 50259.777, "text_hl": "The aim of this study was to develop a novel treatment for @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@PAH@@@ using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Chida-Nagai A, Masaki N, Sato H, Kato T, Takakuwa E, Matsuno Y, Manabe A, Takeda A. Pulmonary artery-targeted low-dose metformin-loaded nanocapsules safely improve pulmonary arterial hypertension in rats. Front Pharmacol. 2025;16():1577570. PMID: 40371328", "BibTeX": "@article{40371328, title={Pulmonary artery-targeted low-dose metformin-loaded nanocapsules safely improve pulmonary arterial hypertension in rats.}, author={Chida-Nagai A and Masaki N and Sato H and Kato T and Takakuwa E and Matsuno Y and Manabe A and Takeda A}, journal={Front Pharmacol}, volume={16}, pages={1577570}}"}}, {"_id": "32394851", "pmid": 32394851, "title": "[Antihypertensive and Vasoprotective Effects of Combined Pharmacotherapy in Patients with Arterial Hypertension and Prediabetes].", "journal": "Kardiologiia", "authors": ["Skibitskiy VV", "Gutova SR", "Fendrikova AV", "Skibitskiy AV"], "date": "2020-04-13T00:00:00Z", "doi": "10.18087/cardio.2020.4.n1112", "meta_date_publication": "2020 Apr 13", "meta_volume": "60", "meta_issue": "4", "meta_pages": "10-17", "score": 50259.145, "text_hl": "Antihypertensive and vasoprotective effects of the @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@+@CHEMICAL_moxonidine @CHEMICAL_MESH:C043482 @@@moxonidin@@@+@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@+indopamide SR+@CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ combinations were comparable.Conclusion The observed statistically significant antihypertensive and vasoprotective effects of the @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@+@CHEMICAL_moxonidine @CHEMICAL_MESH:C043482 @@@moxonidin@@@+@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ combination along with its known positive metabolic effect allow recommendation of this combination therapy to @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@AH@@@ and @DISEASE_Prediabetic_State @DISEASE_MESH:D011236 @@@prediabetes@@@ as an effective strategy for BP control.", "citations": {"NLM": "Skibitskiy VV, Gutova SR, Fendrikova AV, Skibitskiy AV. [Antihypertensive and Vasoprotective Effects of Combined Pharmacotherapy in Patients with Arterial Hypertension and Prediabetes]. Kardiologiia. 2020 Apr 13;60(4):10-17. PMID: 32394851", "BibTeX": "@article{32394851, title={[Antihypertensive and Vasoprotective Effects of Combined Pharmacotherapy in Patients with Arterial Hypertension and Prediabetes].}, author={Skibitskiy VV and Gutova SR and Fendrikova AV and Skibitskiy AV}, journal={Kardiologiia}, volume={60}, number={4}, pages={10-17}}"}}, {"_id": "40195776", "pmid": 40195776, "title": "Potential of Combination Pharmacotherapy in Patients with Arterial Hypertension and Prediabetes: Focus on Organ Protection.", "journal": "Kardiologiia", "authors": ["Skibitsky VV", "Gutova SR", "Fendrikova AV"], "date": "2025-03-31T00:00:00Z", "doi": "10.18087/cardio.2025.3.n2902", "meta_date_publication": "2025 Mar 31", "meta_volume": "65", "meta_issue": "3", "meta_pages": "26-34", "score": 50256.945, "text_hl": "Aim    To compare the effects of two combined antihypertensive therapies on indices of the structural and functional state of the left ventricular (LV) myocardium and intrarenal vascular resistance in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@arterial hypertension@@@ (@<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@AH@@@) and @DISEASE_Prediabetic_State @DISEASE_MESH:D011236 @@@prediabetes@@@.Material and methods    The study included 80 @SPECIES_9606 @@@patients@@@ with poorly controlled @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@AH@@@ and @DISEASE_Prediabetic_State @DISEASE_MESH:D011236 @@@prediabetes@@@ who were randomized into two groups: @SPECIES_9606 @@@patients@@@ in group 1 (n=40) received @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@ at a starting dose of 5 mg/day, sustained-release @CHEMICAL_Indapamide @CHEMICAL_MESH:D007190 @@@indapamide@@@ 1.5 mg/day, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 1000 mg/day; @SPECIES_9606 @@@patients@@@ in group 2 (n=40) received @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@ 5 mg/day, @CHEMICAL_moxonidine @CHEMICAL_MESH:C043482 @@@moxonidine@@@ at a starting dose of 0.2 mg/day, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 1000 mg/day. ", "citations": {"NLM": "Skibitsky VV, Gutova SR, Fendrikova AV. Potential of Combination Pharmacotherapy in Patients with Arterial Hypertension and Prediabetes: Focus on Organ Protection. Kardiologiia. 2025 Mar 31;65(3):26-34. PMID: 40195776", "BibTeX": "@article{40195776, title={Potential of Combination Pharmacotherapy in Patients with Arterial Hypertension and Prediabetes: Focus on Organ Protection.}, author={Skibitsky VV and Gutova SR and Fendrikova AV}, journal={Kardiologiia}, volume={65}, number={3}, pages={26-34}}"}}, {"_id": "35147202", "pmid": 35147202, "pmcid": "PMC8904078", "title": "Metformin inhibits pulmonary artery smooth muscle cell proliferation by upregulating p21 via NONRATT015587.2", "journal": "Int J Mol Med", "authors": ["Sun Z", "Liu Y", "Hu R", "Wang T", "Li Y", "Liu N"], "date": "2022-04-01T00:00:00Z", "doi": "10.3892/ijmm.2022.5104", "meta_date_publication": "2022 Apr", "meta_volume": "49", "meta_issue": "4", "meta_pages": "", "score": 50255.84, "text_hl": "In the current study, a @CHEMICAL_Monocrotaline @CHEMICAL_MESH:D016686 @@@monocrotaline@@@ (@CHEMICAL_Monocrotaline @CHEMICAL_MESH:D016686 @@@MCT@@@)-induced @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@PAH@@@ @SPECIES_10116 @@@rat@@@ model and cultured pulmonary artery smooth muscle cells (PASMCs) were used in vitro to elucidate the exact mechanism of NONRATT015587.2 in @DISEASE_Vascular_Remodeling @DISEASE_MESH:D066253 @@@pulmonary vascular remodeling@@@, alongside the effect following @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@GENE_SLTM @GENE_79811 @@@MET@@@) treatment on @DISEASE_Vascular_Remodeling @DISEASE_MESH:D066253 @@@vascular remodeling@@@ and smooth muscle cell proliferation. ", "citations": {"NLM": "Sun Z, Liu Y, Hu R, Wang T, Li Y, Liu N. Metformin inhibits pulmonary artery smooth muscle cell proliferation by upregulating p21 via NONRATT015587.2 Int J Mol Med. 2022 Apr;49(4):. PMID: 35147202", "BibTeX": "@article{35147202, title={Metformin inhibits pulmonary artery smooth muscle cell proliferation by upregulating p21 via NONRATT015587.2}, author={Sun Z and Liu Y and Hu R and Wang T and Li Y and Liu N}, journal={Int J Mol Med}, volume={49}, number={4}}"}}, {"_id": "33237184", "pmid": 33237184, "title": "The effect of Roux-en-Y gastric bypass in the treatment of hypertension and diabetes.", "journal": "Rev Col Bras Cir", "authors": ["Marchetti G", "Ardengh AO", "Colombo-Souza P", "Kassab P", "Freitas-Jr WR", "Ilias EJ"], "date": "2020-11-23T00:00:00Z", "doi": "10.1590/0100-6991e-20202655", "meta_date_publication": "2020", "meta_volume": "47", "meta_issue": "", "meta_pages": "e20202655", "score": 50246.09, "text_hl": "It is considered a risk factor for @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@systemic arterial hypertension@@@ (@<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@SAH@@@) and @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ T2DM. ", "citations": {"NLM": "Marchetti G, Ardengh AO, Colombo-Souza P, Kassab P, Freitas-Jr WR, Ilias EJ. The effect of Roux-en-Y gastric bypass in the treatment of hypertension and diabetes. Rev Col Bras Cir. 2020;47():e20202655. PMID: 33237184", "BibTeX": "@article{33237184, title={The effect of Roux-en-Y gastric bypass in the treatment of hypertension and diabetes.}, author={Marchetti G and Ardengh AO and Colombo-Souza P and Kassab P and Freitas-Jr WR and Ilias EJ}, journal={Rev Col Bras Cir}, volume={47}, pages={e20202655}}"}}, {"_id": "31579458", "pmid": 31579458, "pmcid": "PMC6759611", "title": "Chronic dosing with metformin plus bosentan decreases in vitro pulmonary artery contraction from isolated arteries in adults with pulmonary hypertension", "journal": "J Cardiovasc Thorac Res", "authors": ["Liao S", "Li D", "Hui Z", "McLachlan CS", "Zhang Y"], "date": "2019-01-01T00:00:00Z", "doi": "10.15171/jcvtr.2019.32", "meta_date_publication": "2019", "meta_volume": "11", "meta_issue": "3", "meta_pages": "189-195", "score": 50076.637, "text_hl": "Animal studies reveal that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ reverses the development of experimental @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@PAH@@@ in @SPECIES_10116 @@@rats@@@, suggesting that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may have additional treatment benefits in PAHs. ", "citations": {"NLM": "Liao S, Li D, Hui Z, McLachlan CS, Zhang Y. Chronic dosing with metformin plus bosentan decreases in vitro pulmonary artery contraction from isolated arteries in adults with pulmonary hypertension J Cardiovasc Thorac Res. 2019;11(3):189-195. PMID: 31579458", "BibTeX": "@article{31579458, title={Chronic dosing with metformin plus bosentan decreases in vitro pulmonary artery contraction from isolated arteries in adults with pulmonary hypertension}, author={Liao S and Li D and Hui Z and McLachlan CS and Zhang Y}, journal={J Cardiovasc Thorac Res}, volume={11}, number={3}, pages={189-195}}"}}, {"_id": "19814724", "pmid": 19814724, "title": "Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension.", "journal": "Br J Pharmacol", "authors": ["Agard C", "Rolli-Derkinderen M", "Dumas-de-La-Roque E", "Rio M", "Sagan C", "Savineau JP", "Loirand G", "Pacaud P"], "date": "2009-11-01T00:00:00Z", "doi": "10.1111/j.1476-5381.2009.00445.x", "meta_date_publication": "2009 Nov", "meta_volume": "158", "meta_issue": "5", "meta_pages": "1285-94", "score": 50065.484, "text_hl": "We thus examined the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@PAH@@@. ", "citations": {"NLM": "Agard C, Rolli-Derkinderen M, Dumas-de-La-Roque E, Rio M, Sagan C, Savineau JP, Loirand G, Pacaud P. Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension. Br J Pharmacol. 2009 Nov;158(5):1285-94. PMID: 19814724", "BibTeX": "@article{19814724, title={Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension.}, author={Agard C and Rolli-Derkinderen M and Dumas-de-La-Roque E and Rio M and Sagan C and Savineau JP and Loirand G and Pacaud P}, journal={Br J Pharmacol}, volume={158}, number={5}, pages={1285-94}}"}}, {"_id": "26978596", "pmid": 26978596, "pmcid": "PMC4795089", "title": "Activation of AMPK Prevents Monocrotaline-Induced Extracellular Matrix Remodeling of Pulmonary Artery", "journal": "Med Sci Monit Basic Res", "authors": ["Li S", "Han D", "Zhang Y", "Xie X", "Ke R", "Zhu Y", "Liu L", "Song Y", "Yang L", "Li M"], "date": "2016-03-09T00:00:00Z", "doi": "10.12659/MSMBR.897505", "meta_date_publication": "2016 Mar 9", "meta_volume": "22", "meta_issue": "", "meta_pages": "27-33", "score": 50061.215, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ prevented @CHEMICAL_Monocrotaline @CHEMICAL_MESH:D016686 @@@MCT@@@-induced @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@pulmonary artery hypertension@@@. ", "citations": {"NLM": "Li S, Han D, Zhang Y, Xie X, Ke R, Zhu Y, Liu L, Song Y, Yang L, Li M. Activation of AMPK Prevents Monocrotaline-Induced Extracellular Matrix Remodeling of Pulmonary Artery Med Sci Monit Basic Res. 2016 Mar 9;22():27-33. PMID: 26978596", "BibTeX": "@article{26978596, title={Activation of AMPK Prevents Monocrotaline-Induced Extracellular Matrix Remodeling of Pulmonary Artery}, author={Li S and Han D and Zhang Y and Xie X and Ke R and Zhu Y and Liu L and Song Y and Yang L and Li M}, journal={Med Sci Monit Basic Res}, volume={22}, pages={27-33}}"}}]}